Bivalent mRNA-1273.214 elicits better response against omicron
Sep 27, 2022
A booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, the original Moderna vaccine, with no new safety concerns.
Lifting of states of emergency effectively ends many pandemic regulations for some senior living providers
By
Kimberly Bonvissuto
Sep 22, 2022
The lifting of COVID-19 states of emergency in two states — and the rescission of a COVID-19 vaccine mandate in one of the country’s largest cities — effectively ends many pandemic regulations affecting...
First needle-free COVID-19 vaccines receive approval in India, China
Sep 07, 2022
Nasal and inhaled vaccines place doses directly where the virus enters the body, such as in the nose or mouth.
COVID-19 vaccination does not negatively impact fertility
Aug 24, 2022
The findings were seen for women undergoing in vitro fertilization-fresh embryo transfer cycle.
Reformulated booster shots ready by September, White House says
Jul 29, 2022
The Biden administration is working on contracts for the reformulated booster doses.
Nursing home provider settles COVID-19 vaccine fraud suit for $1.75M, denies allegations
By
Kathleen Steele Gaivin
Jul 05, 2022
MorseLife Health System has paid $1.75 million dollars to settle a lawsuit that claimed the nursing home defrauded a Centers for Disease Control and Prevention program. The provider allegedly administered...
U.S. begins targeted vaccine rollout against monkeypox
Jun 29, 2022
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine.
FDA panel supports rollout of tweaked booster shots from Moderna, Pfizer this fall
Jun 29, 2022
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.
COVID-19 vaccines cut mortality with heart failure
Jun 16, 2022
Those who are partially vaccinated and unvaccinated face the same increased risk, whereas boosted and fully vaccinated adults fare best.
One in nine may get delayed large local reaction after Moderna vaccine
Jun 10, 2022
A higher risk was seen among women and among individuals aged 30 to 69 years.